An Act To require the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, to publish a final rule relating to nonclinical testing methods.
Citations are generated automatically from bibliographic data
as a convenience and may not be complete or accurate.
Chicago
U.S. Congress. House. FDA Modernization Act 3.0. H.R. 2821. 119th
Cong., 2nd
sess., Engrossed in House July 20, 2026. https://www.govinfo.gov/app/details/BILLS-119hr2821eh.
APA
Congress, House of Representatives (2026, July 20). FDA Modernization Act 3.0 (H.R. 2821 (EH)). Retrieved from https://www.govinfo.gov/app/details/BILLS-119hr2821eh.
MLA
United States, Congress, House of Representatives. FDA Modernization Act 3.0. U.S. Government Publishing Office, https://www.govinfo.gov/app/details/BILLS-119hr2821eh. 119th Congress, H.R. 2821, Engrossed in House 20 Jul. 2026.
Bluebook
H.R.2821 - 119th Congress (2025-2026): FDA Modernization Act 3.0, H.R.2821, 119th Cong. (2026), https://www.govinfo.gov/app/details/BILLS-119hr2821eh.
